RESEARCH FRONTIERS INC Logo

RESEARCH FRONTIERS INC

Develops and licenses patented light-control technology for smart glass applications.

REFR | US

Overview

Corporate Details

ISIN(s):
US7609111072
LEI:
Country:
United States of America
Address:
240 CROSSWAYS PARK DR, WOODBURY

Description

Research Frontiers Inc. is a technology company that develops and licenses its patented Suspended Particle Device (SPD) light-control technology. Marketed as SPD-SmartGlass, this technology enables glass and plastic surfaces to instantly and precisely switch from clear to a user-controlled level of tint. The system operates via a film containing microscopic particles that align when an electrical voltage is applied, regulating the passage of light. Key features include rapid transition speed, variable tint control, and the ability to block over 99% of UV radiation and significant heat, enhancing energy efficiency. The company licenses its technology to a global network of partners for use in products across the automotive, aviation, marine, rail, and architectural industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 17:02
10-Q
English 589.0 KB
2025-10-17 17:15 English 7.8 KB
2025-09-15 10:35
8-K
English 100.4 KB
2025-08-07 18:01
10-Q
English 592.5 KB
2025-06-13 18:57
8-K
English 67.2 KB
2025-05-08 18:01
10-Q
English 598.3 KB
2025-04-30 18:01 English 221.9 KB
2025-04-15 20:05 English 102.5 KB
2025-03-06 17:01 English 11.7 MB
2025-01-02 19:48 English 7.0 KB
2025-01-02 19:48 English 7.0 KB
2025-01-02 19:48 English 7.1 KB
2025-01-02 19:47 English 7.1 KB
2025-01-02 19:47 English 7.1 KB
2024-11-07 17:01 English 579.5 KB

Automate Your Workflow. Get a real-time feed of all RESEARCH FRONTIERS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RESEARCH FRONTIERS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RESEARCH FRONTIERS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.